These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5420622)

  • 1. Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
    Samuel P; Holtzman CM; Meilman E; Sekowski I
    Circulation; 1970 Jan; 41(1):109-14. PubMed ID: 5420622
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of combined administration of clofibrate and neomycin on serum cholesterol levels in familial type II hyperlipoproteinaemia.
    Teoh PC
    Curr Med Res Opin; 1973; 1(9):535-9. PubMed ID: 4779250
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of clofibrate on the serum triglyceride concentration in normal males fed high-sucrose diets.
    Zakim D; Herman RH
    J Atheroscler Res; 1969; 10(1):91-5. PubMed ID: 5380907
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO; Friedman M
    Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.
    Sodhi HS; Kudchodkar BJ; Horlick L; Weder CH
    Metabolism; 1971 Apr; 20(4):348-59. PubMed ID: 5550302
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
    Nordoy A; Gjone E
    Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of clofibrate on spontaneous arteriosclerosis in rats.
    Tucker MJ
    Atherosclerosis; 1971; 13(2):255-65. PubMed ID: 4254399
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
    Craig GM; Walton KW
    Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
    Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
    Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of short-term use of clofibrate on the blood level of cholesterol, beta lipoproteins and free fatty acids].
    Modzelewski A; Zaczek-Modzelewska T
    Wiad Lek; 1970 Nov; 23(21):1937-9. PubMed ID: 5485649
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 19. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential drug therapy of the hyperlipoproteinaemias. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):suppl 63-5. PubMed ID: 1052927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.